TWST Twist Bioscience Corporation

Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company was founded in 2013 and is headquartered in San Francisco, California.

$81.09  -9.99 (-10.96%)
As of 12/03/2021 15:59:56 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Mid cap
GICS sector:  Health Care
Industry:  Diagnostics & Research
Index country:  USA
Country of incorporation:  USA
IPO date:  10/31/2018
Outstanding shares:  49,632,483
Average volume:  655,907
Market cap:   $4,520,030,227
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    90184D100
ISIN:        US90184D1000
Sedol:      BGKG6G7
Valuation   (See tab for details)
PE ratio:   -26.48
PB ratio:   6.91
PS ratio:   47.87
Return on equity:   -20,527.98%
Net income %:   -126.28%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy